Selected research
Market Structure
Global Chloroquine Phosphate Tablets (COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Chloroquine Phosphate Tablets (COVID-19) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Chloroquine Phosphate Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Chloroquine Phosphate Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chloroquine Phosphate Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Chloroquine Phosphate Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Chloroquine Phosphate Tablets (COVID-19) include Zhongsheng Pharma, Sichuan Sunny Hope, CSPC Group, Shanghai Pharma, KPC Group, Jinghua Pharmaceutical Group, North China Pharmaceutical Group, Guangzhou Baiyunshan Guanghua Pharmaceutical and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Chloroquine Phosphate Tablets (COVID-19) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Chloroquine Phosphate Tablets (COVID-19) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Chloroquine Phosphate Tablets (COVID-19) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chloroquine Phosphate Tablets (COVID-19) market size, projected growth trends, production technologies, key applications, and end-use industries.
Chloroquine Phosphate Tablets (COVID-19) Segment by Company
Zhongsheng Pharma
Sichuan Sunny Hope
CSPC Group
Shanghai Pharma
KPC Group
Jinghua Pharmaceutical Group
North China Pharmaceutical Group
Guangzhou Baiyunshan Guanghua Pharmaceutical
Bayer
Sun Pharma
Rising Pharmaceutical
Chloroquine Phosphate Tablets (COVID-19) Segment by Type
250mg
500mg
Chloroquine Phosphate Tablets (COVID-19) Segment by Application
Arthritis
Malaria
COVID-19
Others
Chloroquine Phosphate Tablets (COVID-19) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Phosphate Tablets (COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Phosphate Tablets (COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Phosphate Tablets (COVID-19).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Chloroquine Phosphate Tablets (COVID-19) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chloroquine Phosphate Tablets (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chloroquine Phosphate Tablets (COVID-19) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Chloroquine Phosphate Tablets (COVID-19) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 250mg
- 500mg
Applications
- Arthritis
- Malaria
- COVID-19
- Others
Companies covered
- Zhongsheng Pharma
- Sichuan Sunny Hope
- CSPC Group
- Shanghai Pharma
- KPC Group
- Jinghua Pharmaceutical Group
- North China Pharmaceutical Group
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- Bayer
- Sun Pharma
- Rising Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Chloroquine Phosphate Tablets (COVID-19) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Chloroquine Phosphate Tablets (COVID-19) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Chloroquine Phosphate Tablets (COVID-19) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Chloroquine Phosphate Tablets (COVID-19) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Chloroquine Phosphate Tablets (COVID-19) Market Dynamics
- 2.1 Chloroquine Phosphate Tablets (COVID-19) Industry Trends
- 2.2 Chloroquine Phosphate Tablets (COVID-19) Industry Drivers
- 2.3 Chloroquine Phosphate Tablets (COVID-19) Industry Opportunities and Challenges
- 2.4 Chloroquine Phosphate Tablets (COVID-19) Industry Restraints
3 Chloroquine Phosphate Tablets (COVID-19) Market by Manufacturers
- 3.1 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Manufacturers (2021-2026)
- 3.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Manufacturers (2021-2026)
- 3.3 Global Chloroquine Phosphate Tablets (COVID-19) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Chloroquine Phosphate Tablets (COVID-19) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Chloroquine Phosphate Tablets (COVID-19) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Chloroquine Phosphate Tablets (COVID-19) Manufacturers, Product Type & Application
- 3.7 Global Chloroquine Phosphate Tablets (COVID-19) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Chloroquine Phosphate Tablets (COVID-19) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Chloroquine Phosphate Tablets (COVID-19) Players Market Share by Revenue in 2025
- 3.8.3 2025 Chloroquine Phosphate Tablets (COVID-19) Tier 1, Tier 2, and Tier 3
4 Chloroquine Phosphate Tablets (COVID-19) Market by Type
- 4.1 Chloroquine Phosphate Tablets (COVID-19) Type Introduction
- 4.1.1 250mg
- 4.1.2 500mg
- 4.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Type
- 4.2.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Type (2021-2032)
- 4.2.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Market Share by Type (2021-2032)
- 4.3 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Type
- 4.3.1 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Type (2021-2032)
- 4.3.3 Global Chloroquine Phosphate Tablets (COVID-19) Revenue Market Share by Type (2021-2032)
5 Chloroquine Phosphate Tablets (COVID-19) Market by Application
- 5.1 Chloroquine Phosphate Tablets (COVID-19) Application Introduction
- 5.1.1 Arthritis
- 5.1.2 Malaria
- 5.1.3 COVID-19
- 5.1.4 Others
- 5.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Application
- 5.2.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Application (2021-2032)
- 5.2.3 Global Chloroquine Phosphate Tablets (COVID-19) Sales Market Share by Application (2021-2032)
- 5.3 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Application
- 5.3.1 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Application (2021-2032)
- 5.3.3 Global Chloroquine Phosphate Tablets (COVID-19) Revenue Market Share by Application (2021-2032)
6 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region
- 6.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region (2021-2032)
- 6.2.1 Global Chloroquine Phosphate Tablets (COVID-19) Sales by Region (2021-2026)
- 6.2.2 Global Chloroquine Phosphate Tablets (COVID-19) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Chloroquine Phosphate Tablets (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Chloroquine Phosphate Tablets (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Chloroquine Phosphate Tablets (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Chloroquine Phosphate Tablets (COVID-19) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Chloroquine Phosphate Tablets (COVID-19) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Region
- 7.1 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Region
- 7.1.1 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Region (2021-2026)
- 7.1.3 Global Chloroquine Phosphate Tablets (COVID-19) Revenue by Region (2027-2032)
- 7.1.4 Global Chloroquine Phosphate Tablets (COVID-19) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Chloroquine Phosphate Tablets (COVID-19) Revenue (2021-2032)
- 7.2.2 North America Chloroquine Phosphate Tablets (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Chloroquine Phosphate Tablets (COVID-19) Revenue (2021-2032)
- 7.3.2 Europe Chloroquine Phosphate Tablets (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Chloroquine Phosphate Tablets (COVID-19) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Chloroquine Phosphate Tablets (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Chloroquine Phosphate Tablets (COVID-19) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Chloroquine Phosphate Tablets (COVID-19) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zhongsheng Pharma
- 8.1.1 Zhongsheng Pharma Company Information
- 8.1.2 Zhongsheng Pharma Business Overview
- 8.1.3 Zhongsheng Pharma Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zhongsheng Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.1.5 Zhongsheng Pharma Recent Developments
- 8.2 Sichuan Sunny Hope
- 8.2.1 Sichuan Sunny Hope Company Information
- 8.2.2 Sichuan Sunny Hope Business Overview
- 8.2.3 Sichuan Sunny Hope Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sichuan Sunny Hope Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.2.5 Sichuan Sunny Hope Recent Developments
- 8.3 CSPC Group
- 8.3.1 CSPC Group Company Information
- 8.3.2 CSPC Group Business Overview
- 8.3.3 CSPC Group Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CSPC Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.3.5 CSPC Group Recent Developments
- 8.4 Shanghai Pharma
- 8.4.1 Shanghai Pharma Company Information
- 8.4.2 Shanghai Pharma Business Overview
- 8.4.3 Shanghai Pharma Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanghai Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.4.5 Shanghai Pharma Recent Developments
- 8.5 KPC Group
- 8.5.1 KPC Group Company Information
- 8.5.2 KPC Group Business Overview
- 8.5.3 KPC Group Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 KPC Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.5.5 KPC Group Recent Developments
- 8.6 Jinghua Pharmaceutical Group
- 8.6.1 Jinghua Pharmaceutical Group Company Information
- 8.6.2 Jinghua Pharmaceutical Group Business Overview
- 8.6.3 Jinghua Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Jinghua Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.6.5 Jinghua Pharmaceutical Group Recent Developments
- 8.7 North China Pharmaceutical Group
- 8.7.1 North China Pharmaceutical Group Company Information
- 8.7.2 North China Pharmaceutical Group Business Overview
- 8.7.3 North China Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 North China Pharmaceutical Group Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.7.5 North China Pharmaceutical Group Recent Developments
- 8.8 Guangzhou Baiyunshan Guanghua Pharmaceutical
- 8.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
- 8.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
- 8.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.8.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
- 8.9 Bayer
- 8.9.1 Bayer Company Information
- 8.9.2 Bayer Business Overview
- 8.9.3 Bayer Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Bayer Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.9.5 Bayer Recent Developments
- 8.10 Sun Pharma
- 8.10.1 Sun Pharma Company Information
- 8.10.2 Sun Pharma Business Overview
- 8.10.3 Sun Pharma Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sun Pharma Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.10.5 Sun Pharma Recent Developments
- 8.11 Rising Pharmaceutical
- 8.11.1 Rising Pharmaceutical Company Information
- 8.11.2 Rising Pharmaceutical Business Overview
- 8.11.3 Rising Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Rising Pharmaceutical Chloroquine Phosphate Tablets (COVID-19) Product Portfolio
- 8.11.5 Rising Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Chloroquine Phosphate Tablets (COVID-19) Value Chain Analysis
- 9.1.1 Chloroquine Phosphate Tablets (COVID-19) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Chloroquine Phosphate Tablets (COVID-19) Production Mode & Process
- 9.2 Chloroquine Phosphate Tablets (COVID-19) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Chloroquine Phosphate Tablets (COVID-19) Distributors
- 9.2.3 Chloroquine Phosphate Tablets (COVID-19) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst